It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it. The article may be deleted if this message remains in place for seven days, i.e., after 14:25, 19 July 2024 (UTC). Find sources: "Tecrea" – news · newspapers · books · scholar · JSTOR Nominator: Please consider notifying the author/project: {{subst:proposed deletion notify|Tecrea|concern=Fails the [[WP:NCORP|notability guideline for companies]]. Almost exclusively cited to company website. Gets a few passing mentions in academic papers but nothing substantive.}} ~~~~ |
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (July 2020) |
Tecrea Ltd is a biotech company located in the London Bioscience Innovation Centre. The company is involved in research and development to improve the cell and tissue delivery of drugs and reagents. The approach involves nanomedicine, which has the potential to address a wide variety of diseases.[1]
Industry | Biotechnology |
---|---|
Founded | 2012 |
Headquarters | London Bioscience Innovation Centre London, United Kingdom. |
Area served | Worldwide |
Services | Research Reagents,Drug Development |
Website | www |
Recently Tecrea along with Cobra Biologics was awarded the Innovate UK Grant worth £112K to Develop AAV Scalable Production Bioprocess[2]
Background
editFounded in 2012, as a spinout from the Royal Veterinary College, University of London, the company has developed a line of tools aimed at improving scientific experiments through enhanced delivery of a range of molecules into cells.[3]
Products
editTecrea Research Reagents and Drug Formulation products
Research Reagents
editTransfection - Plasmid | siRNA
edit- HappyFect
- When mixed with DNA or RNA, HappyFect forms nanoparticles that enable efficient transfection with low toxicity
- There are two types of HappyFect:
Drug Delivery - Peptide & Protein | Small Molecule
edit- Nanocargo
- Tecrea’s NanoCargo products are aimed at improving the delivery of small molecules, peptides, and proteins, including antibodies, into a range of cell types and tissues. Nanocargo can also deliver cargo molecules into gram negative and gram positive bacteria.
- There are two types of Nanocargo:
Sterility Maintenance
edit- Antimicrobial - SanZone
- SanZone is used to ensure that incubators and water baths remain clean and infection-free. When culturing cells of any type, it is imperative that incubators be effectively sterile areas. The presence of SanZone kills microbes and prevents infection from accumulating in water baths and incubators.[8]
Drug Formulation
edit- Nanocin
- Nanocin is a new platform for nanoparticle-based delivery of small molecules that can be applied to small molecule reagents, drugs and diagnostic probes.[9]